Skip to main content
KARD
NASDAQ Life Sciences

Kardigan Shares Rise 1.6% in Nasdaq Debut After Upsized $400M IPO

Reported by Reuters
Sentiment info
Positive
Importance info
8
Price
$17.72
Mkt Cap
0
52W Low
0
52W High
0
Market data snapshot near publication time

Summary

Kardigan's shares rose 1.6% in their Nasdaq debut, following an upsized $400 million initial public offering. This provides the immediate market reaction to the IPO, which was previously announced as priced and successfully raised earlier today. The positive debut performance indicates strong initial investor interest in the heart drug developer.

At the time of this announcement, KARD was trading at $17.72 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

KARD - Latest Insights

KARD
Jun 18, 2026, 5:14 PM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $20.43
Real-time Price: $22.00 info
Change: +$1.57 (+8%) info
Market Cap: N/A info
KARD
Jun 18, 2026, 12:42 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $17.72
Real-time Price: $22.00 info
Change: +$4.28 (+24%) info
Market Cap: N/A info
KARD
Jun 18, 2026, 5:06 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: N/A
Real-time Price: $22.00 info
Change: N/A info
Market Cap: N/A info
KARD
Jun 17, 2026, 9:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: N/A
Real-time Price: $22.00 info
Change: N/A info
Market Cap: N/A info